Turbine’s Post

BioReact : Bioprocess Meets Ai is pleased to announce that we are a new member of BioMADE, a non-profit, public-private partnership that is securing America’s future through bioindustrial manufacturing innovation, education, and collaboration. We’re excited to join BioMADE’s network of over 200 member organizations around the country. Together with BioMADE and its other members, we look forward to working together to harness the power of biology to create and domestically source the manufactured goods that people use every day. Learn more about BioMADE at www.biomade.org.

💵Honesty pays off - to the tune of £90 million: https://hubs.ly/Q02ZX6lt0 Dr Robin Carr, CEO of Myricx Bio, highlights how transparency about negative data helped them maintain healthy relationship with investors and secure a £90m Series A funding round—the largest for a European biotech spinout. During the recent Imperial Founders Forum event, he shared how by fostering trusting relationships with investors, the team successfully pivoted from small molecules to innovative antibody-drug conjugates (ADCs), turning challenges into breakthroughs. The event included insights from some of our top academic entrepreneurs Professor Richard Craster | Professor Peter Cawley | Dr Andrew Bell | Dr Roberto Solari | Professor Ed Tate | British Patient Capital | The Francis Crick Institute

Calling all early stage biotech founders... Whether you are still at concept/ idea phase or already launched your early stage fundraising, Black Swann Consulting Group would love to help you on your journey. With experience in both scientific, business and fundraising plans and strategies, we'd love to help make your early stage biotech a success. We only win, if you win! Success based fee so we take the risk with you and share the conviction with you! Let's talk! #Biotech #GoToMarket #ProductMarketFit #FounderMarketFit #DrugDiscovery #CommercialLifeScience #LifeScience #BiotechPlatform #TechBio

A lab without Labguru? It wasn't an option for Dr. Alon Silberman, MitoCareX Bio Co-Founder and Chief Scientific Officer. MitoCareX Bio is a successful early-stage drug discovery startup. They've been using Labguru since day 1. With us, they have: ⏱️ Saved 3+ hours every week 💰 Saved $300/month thanks to effective inventory management 🧪 Simplified experiment planning & improved consistency of results 🗃️ Made lab data centralized, searchable, and traceable We interviewed Dr. Alon Silberman, MitoCareX Bio Co-Founder and Chief Scientific Officer, to discover why he couldn't imagine lab life without Labguru. This is what he said 👇 📌Full Case study: https://bit.ly/4dEDQfn

Creating a platform to integrate diverse chronic disease data sets from the Accelerating Medicines Partnership. The Common Fund Venture Program SysBio Initiative has announced its first award to integrate various data types collected through the Accelerating Medicines Partnership, a public-private partnership with the goal of improving the development of new diagnostics and treatments for chronic disease. The Venture Program SysBio Initiative will create a centralized portal and tools to allow researchers to search for data across existing platforms to connect datasets to answer new scientific questions. Learn more about the new award for the Venture Program SysBio Initiative: https://go.nih.gov/2X1kAfU Get the latest information about the Venture Program SysBio Initiative: https://lnkd.in/eSvEw-MZ #SysBio #Datasets #SystemsBiology #FAIRprinciples #AcceleratingMedicinesPartnership

Creating a platform to integrate diverse chronic disease data sets from the Accelerating Medicines Partnership. The Common Fund Venture Program SysBio Initiative has announced its first award to integrate various data types collected through the Accelerating Medicines Partnership, a public-private partnership with the goal of improving the development of new diagnostics and treatments for chronic disease. The Venture Program SysBio Initiative will create a centralized portal and tools to allow researchers to search for data across existing platforms to connect datasets to answer new scientific questions. Learn more about the new award for the Venture Program SysBio Initiative: https://go.nih.gov/2X1kAfU Get the latest information about the Venture Program SysBio Initiative: https://lnkd.in/eSvEw-MZ #SysBio #Datasets #SystemsBiology #FAIRprinciples #AcceleratingMedicinesPartnership

5 days until Data & Drinks! This Buzzed for Biotech networking and fireside chat event is for scientists who handle data, data pros, and executives who want to get insight into how others are managing their data. How you do this can dictate what information you're able to extract from your data, and how efficient you can be working with that data. I've seen many people burn through piles of cash because this wasn't a priority. Also, who the heck wants to spend hours every day manually curating data and tweaking the same scripts over and over again to make them work with new datasets? I did this during my PhD and... it was awful. I've learned better ways since. -- I know Liyang Diao understands this and is why I invited her to join the fireside chat panel! She will provide a unique perspective on the topic as she has lead data teams in small-medium sized companies focusing on microbiome, oncology, and autoimmune disease research. (I've also known Liyang for 2-3 years now and have only ever chatted virtually... so I'm very much looking forward to finally meeting in person!) -- Event sponsored by Collaborative Drug Discovery - CDD Vault and dovetail biopartners. Organized by Ralf Felsner and myself. You have to RSVP for this one to get in, so make sure to do that: https://lu.ma/k3h7is11 -- Look out for more post leading up to the event highlighting other panel members! #networking #biotech #lifesciences #datascience

🚀 We are thrilled to share that Ryght has been selected to join the prestigious 2024 BioTools Innovator cohort! 🎉 We are eager to collaborate with an ecosystem of talented partners, strategics, and industry leaders throughout this incredible accelerator program. Stay tuned for updates as we work together to bring efficiency solutions to the forefront of #clinicaltrials and #clinicalresearch. Discover more about the amazing technology and solutions from all the cohort companies in the official press release below. #IamAnInnovator #Biotech #TechBio #BTI #Diagnostics #BioTools #LifeScienceTools

The wait is over! Fierce Biotech Fierce 15 is here! Nominations starting today in search of the best and brightest in biotech.  Send in your suggestions for the fiercest companies in the game now! 👉 https://lnkd.in/eMqebHWa 📢 Follow Fierce Life Sciences Events for the latest news and updates #FierceBiotech #FiercePharma #Fierce15

Enveda, a Boulder-based AI-powered medicine developer from natural compounds, raised $130 million in Series C funding. Kinnevik and FPV led the round and were joined by Baillie Gifford, Premji Invest, Lingotto Innovation, and others. https://lnkd.in/dZeZcm34 #funding #natural #medicine #development #ai